MARKET

OGEN

OGEN

ORAGENICS
AMEX

Real-time Quotes | Nasdaq Last Sale

0.4685
+0.0085
+1.85%
After Hours: 0.4649 -0.0036 -0.77% 17:56 11/11 EST
OPEN
0.4700
PREV CLOSE
0.4600
HIGH
0.4700
LOW
0.4500
VOLUME
709.12K
TURNOVER
--
52 WEEK HIGH
1.670
52 WEEK LOW
0.3500
MARKET CAP
21.61M
P/E (TTM)
-0.6055
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OGEN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OGEN News

  • Oragenics Highlights Senior VP of Discovery Research, Martin Handfield, Will Be Featured Speaker At International Conference on Microbial Research and Applications Nov. 13, 2019
  • Benzinga.8h ago
  • Oragenics, Inc. SVP of Discovery Research, Martin Handfield, Ph.D. to Be Featured Speaker at the International Conference on Microbial Research and Applications
  • Business Wire.8h ago
  • Oragenics (OGEN) Investor Presentation - Slideshow
  • Seeking Alpha - Article.10/24 11:19
  • Oragenics, Inc. to Present at the BIO Investor Forum
  • Business Wire.10/22 12:00

More

Industry

Biotechnology & Medical Research
-0.51%
Pharmaceuticals & Medical Research
-0.43%

Hot Stocks

Name
Price
%Change

About OGEN

Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.
More

Webull offers Oragenics Inc (OGEN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.